Non-traditional risk factors for Atherosclerosis

Non-traditional risk factors for Atherosclerosis

During the last 10 years, several "non-traditional" risk markers for atherosclerosis have been identified. Among them, new markers of lipoprotein metabolism (ie lipoprotein [ a]), endothelial dysfunction (ie homocysteine), hemostasis (ie fibrinogen) and inflammation (ie C-reactive protein) have been linked to an excessive risk of cardiovascular disease. These factors should help the clinician to better identify individuals at risk of premature atherosclerotic disease and/or improve the predictive value of established risk factors for atherosclerosis. Finally, these factors are expected to improve the knowledge in the pathophysiology of cardiovascular diseases, and perhaps to impact future therapeutic decisions. In this review article, we will analyze the markers in which there are at least some evidence to support their acceptance as "non-traditional risk factors" for atherosclerotic disease (Rev Méd Chile 2001; 129: 1212-21)

Saved in:
Bibliographic Details
Main Authors: Acevedo,Mónica, Tagle,Rodrigo, Simpfendorfer,Conrad
Format: Digital revista
Language:English
Published: Sociedad Médica de Santiago 2001
Online Access:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872001001000016
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0034-98872001001000016
record_format ojs
spelling oai:scielo:S0034-988720010010000162005-11-14Non-traditional risk factors for AtherosclerosisAcevedo,MónicaTagle,RodrigoSimpfendorfer,Conrad C-reactive protein Fibrinogen Homocysteine Lipoprotein (a) Risk factors During the last 10 years, several "non-traditional" risk markers for atherosclerosis have been identified. Among them, new markers of lipoprotein metabolism (ie lipoprotein [ a]), endothelial dysfunction (ie homocysteine), hemostasis (ie fibrinogen) and inflammation (ie C-reactive protein) have been linked to an excessive risk of cardiovascular disease. These factors should help the clinician to better identify individuals at risk of premature atherosclerotic disease and/or improve the predictive value of established risk factors for atherosclerosis. Finally, these factors are expected to improve the knowledge in the pathophysiology of cardiovascular diseases, and perhaps to impact future therapeutic decisions. In this review article, we will analyze the markers in which there are at least some evidence to support their acceptance as "non-traditional risk factors" for atherosclerotic disease (Rev Méd Chile 2001; 129: 1212-21)info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.129 n.10 20012001-10-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872001001000016en10.4067/S0034-98872001001000016
institution SCIELO
collection OJS
country Chile
countrycode CL
component Revista
access En linea
databasecode rev-scielo-cl
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Acevedo,Mónica
Tagle,Rodrigo
Simpfendorfer,Conrad
spellingShingle Acevedo,Mónica
Tagle,Rodrigo
Simpfendorfer,Conrad
Non-traditional risk factors for Atherosclerosis
author_facet Acevedo,Mónica
Tagle,Rodrigo
Simpfendorfer,Conrad
author_sort Acevedo,Mónica
title Non-traditional risk factors for Atherosclerosis
title_short Non-traditional risk factors for Atherosclerosis
title_full Non-traditional risk factors for Atherosclerosis
title_fullStr Non-traditional risk factors for Atherosclerosis
title_full_unstemmed Non-traditional risk factors for Atherosclerosis
title_sort non-traditional risk factors for atherosclerosis
description During the last 10 years, several "non-traditional" risk markers for atherosclerosis have been identified. Among them, new markers of lipoprotein metabolism (ie lipoprotein [ a]), endothelial dysfunction (ie homocysteine), hemostasis (ie fibrinogen) and inflammation (ie C-reactive protein) have been linked to an excessive risk of cardiovascular disease. These factors should help the clinician to better identify individuals at risk of premature atherosclerotic disease and/or improve the predictive value of established risk factors for atherosclerosis. Finally, these factors are expected to improve the knowledge in the pathophysiology of cardiovascular diseases, and perhaps to impact future therapeutic decisions. In this review article, we will analyze the markers in which there are at least some evidence to support their acceptance as "non-traditional risk factors" for atherosclerotic disease (Rev Méd Chile 2001; 129: 1212-21)
publisher Sociedad Médica de Santiago
publishDate 2001
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872001001000016
work_keys_str_mv AT acevedomonica nontraditionalriskfactorsforatherosclerosis
AT taglerodrigo nontraditionalriskfactorsforatherosclerosis
AT simpfendorferconrad nontraditionalriskfactorsforatherosclerosis
_version_ 1755988058219479040

Similar Items